However, there are particular contexts wherein the evidence appears consistent and persuasive: the positive association between type 2 diabetes risk alleles in TCF7L2 and higher risk of breast and colorectal cancer; and the association between type 2 diabetes predisposing alleles and lower risk of prostate cancer. Here, TCF7L2 is linked to Familial prostate cancer.